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Sortases function as cysteine transpeptidases that catalyze the covalent attachment of
virulence-associated surface proteins into the cell wall peptidoglycan in Gram-positive
bacteria. The substrate proteins targeted by sortase enzymes have a cell wall sorting
signal (CWSS) located at the C-terminus. Up to date, it is still not well understood how
sortases with structural resemblance among different classes and diverse species of
bacteria achieve substrate specificity. In this study, we focus on elucidating the molecular
basis for specific recognition of peptide substrate PPKTG by Clostridium difficile sortase
B (Cd-SrtB). Combining structural studies, biochemical assays and molecular dynamics
simulations, we have constructed a computational model of Cd-SrtB1N26–PPKTG
complex and have validated the model by site-directed mutagensis studies and
fluorescence resonance energy transfer (FRET)-based assay. Furthermore, we have
revealed that the fourth amino acid in the N-terminal direction from cleavage site of
PPKTG forms specific interaction with Cd-SrtB and plays an essential role in configuring
the peptide to allow more efficient substrate-specific cleavage by Cd-SrtB.
Keywords: Clostridium difficile, sortase, substrate specificity, crystal structure, fluorescence resonance energy
transfer
INTRODUCTION
Bacterial surface proteins are crucial virulence factors that mediate adhesion to the host as the first
step establishing an infection. The sortase family of cysteine transpeptidases catalyzes the anchoring
of a wide variety of virulence-associated surface proteins to the cell wall peptidoglycan (Spirig et al.,
2011; Cascioferro et al., 2014; Bradshaw et al., 2015). Sortases, unique to Gram-positive bacteria,
recognize and cleave the C-terminal cell wall sorting signal motif (CWSS) of substrate proteins
(Schneewind et al., 1992, 1993; Paterson and Mitchell, 2004). Based on the primary sequences
and their roles in biological functions, sortases are classified into six classes: A, B, C, D, E, and
F. Class A sortases (SrtAs) are present in almost all Gram-positive bacteria. The first identified
and best-known class A enzyme is the Staphylococcus aureus SrtA (Sa-SrtA), which anchors at
least 19 LPXTG-containing surface proteins (Mazmanian et al., 1999; Perry et al., 2002; Spirig
et al., 2011; Bradshaw et al., 2015). Sa-SrtA mutants exhibited a severe reduced adherence to
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epithelial cells and virulence in animal models (Flock et al., 1987;
Mazmanian et al., 2000; Clancy et al., 2010). SrtAs are commonly
called housekeeping sortases, whereas the remaining five classes
are the accessory sortases. Class B sortases (SrtBs) recognize the
NXXTN motif rather than the classical LPXTG motif and have
distinct functions (Comfort andClubb, 2004; Dramsi et al., 2005);
some members of this group are involved in iron acquisition,
whereas sortase B of Streptococcus pyogenes is involved in pili
assembly (Kang et al., 2011). Class C sortases (SrtCs) are essential
for pili polymerization in many species (Huang et al., 2010),
such as Enterococcus faecalis (Kline et al., 2009),Corynebacterium
diphtheria (Ton-That and Schneewind, 2003; Gaspar and Ton-
That, 2006), Streptococcus agalactiae (Dramsi et al., 2006; Cozzi
et al., 2012), and Streptococcus pneumonia (Fälker et al., 2008;
LeMieux et al., 2008; Manzano et al., 2008). In addition,
SrtC is required for aerial hyphae formation in Streptomyces
coelicolor (Di Berardo et al., 2008). Class D sortases (SrtDs) are
similar to SrtAs and perform a housekeeping role; they most
frequently present in Bacillus species and are involved in spore
formation (Marraffini and Schneewind, 2006). Recent studies
have reported that Clostridium perfringens SrtD is structurally
and catalytically distinct from Bacillus anthracis SrtD, suggesting
that C. perfringens SrtD may display a different aspect of the
SrtD family (Marraffini and Schneewind, 2006; Suryadinata
et al., 2015). Class E and F sortases are mainly identified in
Actinobacteria; they share a limited primary sequence homology
with other sortases and their functions remain undetermined
(Comfort and Clubb, 2004; Dramsi et al., 2005; Spirig et al., 2011).
In the genome of toxigenic C. difficile strain 630, only one
functional sortase, the SrtB gene, is present (Donahue et al.,
2014). C. difficile is a Gram-positive, anaerobic, and spore-
forming bacterium that can colonize the gut if the normal
intestinal microbiota is disrupted (Kelly and LaMont, 1998).
C. difficile infection (CDI) is highly associated with antibiotic
therapy and has been recognized as the leading cause of
antibiotic-associated diarrhea, making it a major public health
threat worldwide (Henrich et al., 2009; Bagdasarian et al., 2015).
In the United States alone, CDI causes approximately 15,000–
20,000 deaths annually, and CDI-associated hospitalizations
among the general population doubled from 31 to 61 per
100,000 from 2008 to 2010 (Viseur et al., 2011). Furthermore,
the CDI risk is high in patients receiving antibiotic treatments
because their gastrointestinal flora is unfavorably altered. CDI
manifestations can include asymptomatic colonization, mild to
severe chronic diarrhea, pseudomembranous colitis, and death
because of multiple organ failure (Kelly and LaMont, 2008). At
present, metronidazole and vancomycin are mainly administered
for treating CDI. However, up to 25% of patients treated for CDI
experience recurrences after discontinuing antibiotic therapy
(Bartlett et al., 1980; Tedesco et al., 1985; Leffler and Lamont,
2009; Surawicz et al., 2013). The increase in treatment failure or
multiple relapses have raised a concern. An alternative therapy,
fecal microbiota transplantation, has been used to restore healthy
gut flora in patients with recurrent CDI (Rohlke and Stollman,
2012; Dodin and Katz, 2014; Duke and Fardy, 2014). Fecal
transplantation is highly effective; however, it is still not widely
accepted. In the last decade, sortase has been identified as a
promising anti-infective therapeutic target (Zong et al., 2004b;
Maresso et al., 2007; Suree et al., 2009; Oh et al., 2010; Jacobitz
et al., 2014; Zhang et al., 2014), thus offering an encouraging
avenue toward the development of drugs against CDI.
There have been many structural and functional studies on
sortases from various Gram-positive pathogens (Spirig et al.,
2011; Cascioferro et al., 2014; Bradshaw et al., 2015), and studies
on C. difficile sortases were reported recently (Donahue et al.,
2014; van Leeuwen et al., 2014; Chambers et al., 2015). Sa-
SrtA has been extensively studied, and the catalytic mechanism
underlying how Sa-SrtA anchors the surface protein to cell wall
has been reported (Mazmanian et al., 1999; Perry et al., 2002).
The membrane-bound Sa-SrtA scans and recognizes the LPXTG
sequence of the CWSS, and a nucleophilic attack from the active
thiol group of sortase cysteine residue to the peptide bond
between the threonine and glycine of the LPXTG motif results
in the formation of a thioester intermediate (Mazmanian et al.,
1999; Ton-That et al., 1999; Perry et al., 2002). The sortase–
acyl intermediate is then resolved by the nucleophilic attack of
a free amino group within lipid II, resulting in the release of
the surface protein from the sortase onto the cross bridge of the
newly formed peptidoglycan (Frankel et al., 2005). This substrate
release restores the enzyme active site, allowing the sortase to
process more substrates (Frankel et al., 2005).
Recent studies have demonstrated that C. difficile SrtB (Cd-
SrtB) can recognize and cleave (S/P)PXTG between threonine
and glycine; however, Cd-SrtB cannot recognize the sequence
LPXTG and NPQTN, corresponding to the recognition motifs
for Sa-SrtA and Sa-SrtB, respectively (van Leeuwen et al., 2014;
Chambers et al., 2015). It remains unclear how structurally
similar sortases achieve substrate specificity. Thus far, the
available structures of sortase–substrate complexes are limited to
the nuclear magnetic resonance structure of Sa-SrtA bound to an
LPATG substrate analog (Suree et al., 2009), a crystal structure
of a Sa-SrtA mutant complexed with LPETG (Zong et al., 2004a),
and a crystal structure of Sa-SrtB covalently bound to an NPQTN
analog (Jacobitz et al., 2014). Therefore, studying and comparing
new structures of sortases and sortase–substrate complexes from
a wide range of organisms will enhance our understanding
of how sortases recognize their respective substrates. In this
study, we determined the crystal structure of the catalytically
active SrtB from C. difficile and constructed a probable model
of the Cd-SrtB–PPKTG complex by computer modeling and
molecular dynamics simulations to gain structural insights into
the substrate specificity for Cd-SrtB.
MATERIALS AND METHODS
Protein Overexpression and Purification
The SrtB1N26 from C. difficile 630 was cloned into a
pMCSG7 vector by using a ligation-independent cloning method
(Aslanidis and de Jong, 1990) and transformed into E. coli
BL21 (DE3). A recombinant 6xHis-tagged SrtB1N26 protein was
induced by adding 0.5mM isopropyl-β-D-thiogalactopyranoside
when the cells reached an O.D.600 of 0.5, and further
incubated at 37◦C for 4 h. Cells were centrifuged at 8000
rpm for 30min at 4◦C, resuspended in buffer A (20mM
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 November 2016 | Volume 6 | Article 160
Yin et al. Substrate Specificity of C. difficile Sortase
HEPES pH 7.4, 200mM NaCl and 20mM imidazole), and
disrupted by sonication on ice. Moreover, the supernatant
was loaded into an Ni-NTA column (GE Healthcare Life
Sciences) and contaminant proteins were eliminated through
a washing procedure by using 60mM imidazole in buffer
A. SrtB1N26 proteins were eluted with 300mM imidazole in
buffer A. Fractions containing SrtB1N26 proteins were pooled
and further purified through HiLoad 26/600 SuperdexTM 75
size-exclusion chromatography (GE Healthcare Life Sciences).
Subsequently, the proteins were dialyzed in buffer B (10mM
HEPES pH 7.4 and 150mM NaCl) and stored at 4◦C for further
use.
FRET-Based Assay
The peptide substrate of Cd-SrtB1N26, PPKTG was conjugated
using a fluorophore, 5-[(2-aminoethyl) amino] naphthalene-1-
sulfonic acid, and a quencher, 4-([4-(dimethylamino) phenyl]
azo) benzoic acid. To determine the suitable concentrations of
Cd-SrtB1N26 and fluorescently labeled PPKTG peptide in the
assay, a matrix of various enzyme and substrate concentrations
in the total volume of 100µL in FRET buffer (10mM HEPES
pH 7.4 and 150mM NaCl) was reacted in a 96-well black
polystyrene plate and was incubated at 37◦C for 48 h. The
fluorescence signal was monitored at an excitation/emission
wavelength of 340/490 nm and recorded every hour during
the first 8 h and then at 24, 36, and 48 h by using a
Spectra-Max M3 plate reader (Molecular Devices). The optimal
concentrations of Cd-SrtB1N26 and fluorogenic peptide used in
our reactions are 240 and 20µM, respectively. Stock solutions
of MTSET and AAEK1 were dissolved in the FRET buffer, and
curcumin was dissolved in DMSO. Serial dilutions of inhibitors
at the millimolar range were added into the FRET buffer. All
experiments were conducted in triplicate. The data are presented
as means and standard errors. The statistical significance
of the inhibitory effect on enzymatic activity was calculated
using GraphPad Prism software (GraphPad Software). Two-
tailed unpaired Student t-tests revealed significant differences
between Cd-SrtB1N26 + PPKTG and Cd-SrtB1N26 + PPKTG +
inhibitors at different concentrations (∗p ≤ 0.05, ∗∗p ≤ 0.01, and
∗∗∗p ≤ 0.001).
Crystallization
Purified Cd-SrtB1N26 proteins were concentrated to 8–10
mg/mL for crystallization trials. For sparse matrix screening,
numerous commercial kits (Hampton Research and Emeralds
BioSystems) were used for performing the crystallization setup
of the vapor diffusion method by using a high-throughput
platform (Digilab Genomic Solutions). Cd-SrtB1N26 crystals
were observed in sitting drops containing 0.5µL of protein
and 0.5µL of various crystallization solutions at 25◦C within
1 week. Diffraction quality crystals were obtained using the
hanging drop method by mixing 1µL of protein (10mg/ml
in 10mM HEPES pH 7.4 and 150mM NaCl) and 1µL
of solution (0.1M citric acid pH 3.5, 24% PEG 3350 and
0.1M glycine). Prior to data collection, the crystals were
directly mounted on loops from mother liquor and flash-
frozen in liquid nitrogen without an additional cryoprotectant
treatment.
X-Ray Data Collection and Processing
Diffraction data were collected on beamline BL13B1 of the
National Synchrotron Radiation Research Center (NSRRC;
Hsinchu, Taiwan) and beamline 4.2.2 of the Advanced Light
Source (Berkeley, CA, USA). Most of our sortase crystals did not
diffract beyond 3 Å resolution. The best crystal diffracted to 2.67
Å resolution and native data were collected at BL13B1 of the
NSRRC. Ninety frames were collected, each with 1◦ oscillation
and were exposed for 30 s at the wavelength of 1.0 Å with
the crystal-to-detector distance of 400mm at a temperature of
100 K. The data were indexed, integrated, and scaled using
HKL2000 (Otwinowski and Minor, 1997). The initial data were
scaled to 2.67 Å resolution, but the I/σI decreased to 1.67 at
the highest resolution shell (2.77−2.67 Å) suggesting that the
data were effective at a resolution of approximately 2.8 Å. The
crystallographic parameters and data collection statistics were
summarized in Table 1.
Structure Determination and Refinement
The crystal structure of Cd-SrtB1N26 was solved by molecular
replacement method by program Phaser-MR (Mccoy et al., 2007)
with the structure of Sa-SrtB (PDB 1QWZ) (Zong et al., 2004a)
as a search model. Initially, the structure was determined at 3.5
Å resolution, and a polyalanine model was constructed. With
the availability of better native datasets at higher resolutions,
the model was manually rebuilt using COOT (Emsley et al.,
2010) guided by 2Fo-Fc and Fo-Fc density maps. Computational
refinement was conducted using REFMAC (Murshudov et al.,
2011) and PHENIX (Adams et al., 2010), with 5% of the data
flagged for cross-validation. We first carried out the refinement
at 2.67 Å resolution, but the statistics were poor. The structural
quality was improved when we systematically excluded the weak
inflections by truncating data at different resolutions. Iterative
model rebuilding and refinement were conducted. The final
refinement statistics for the structural model at 2.8 Å resolution
were summarized in Table 1. Coordinates and structure factors
with the identifier 5GYJ have been deposited in the Protein Data
Bank.
MD Simulations
The peptide of sequence NPQC co-crystalized with S. aureus
SrtB structure (PDB 4LFD) was positioned in the catalytic pocket
of C. difficile SrtB by superimposing of S. aureus SrtB onto
C. difficile SrtB (Cd-SrtB). It was then mutated into a set of
peptides of our interest, including PPKT and NPQT. PPKTG
and NPQTN were modeled by adding one more G and N,
respectively, in the C-terminus using the package VMD 1.9.2
(Humphrey et al., 1996). We further replaced the P4 residue
in PPKTG to give SPKTG and NPKTG. Missing loops of
27–28 (ML), 162–167 (ESDYDY), 210–216 (TYEFDDA), and
225 (I) in the Cd-SrtB were modeled by UCSF CHIMERA
(Yang et al., 2012). Cd-SrtB−peptide complexes were solvated
in TIP3P water molecules of 8Å thickness in all directions of
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TABLE 1 | Crystallographic data and refinement statistics.
DATA COLLECTION
Wavelength (Å) 1.0
Resolution range (Å) 25.9–2.8 (2.9–2.8)a
Space group I23
Unit cell dimensions 121.25, 121.25, 121.25, 90, 90, 90
Total reflections 65563
Unique reflections 7031
Redundancy 9.3 (11.1)
I / σI 45.85 (10.4)
Completeness (%) 94.1 (100)
Rmerge (%) 6.5 (25.9)
Wilson B factor (Å2) 66.9
REFINEMENT
Rwork (%) 19.71
Rfree (%) 25.23
Number of atoms
Protein 1529
Water 38
B-factors (Å2)
Protein 55.74
Water 50.42
Rms deviations
Bond lengths (Å) 0.0098
Bond angles (◦) 1.207
Ramachandran plot statisticsb
% of residues in favored regions 96.0
% of residues in allowed regions 4.0
% of residues in outlier regions 0.0
aThe values in parenthesis are for the highest resolution bin.
bResidues in favored, allowed, and outlier regions of the Ramachandran plot as reported
by MolProbity (Chen et al., 2010).
a rectangular box (Jorgensen et al., 1983). One hundred and
fifty millimolar sodium chloride were added as counter-ions
to neutralize the system. Energy minimization and explicit-
solvent MD simulations were performed by NAMD 2.10
package (Phillips et al., 2005; Huang and MacKerell, 2013) with
CHARMM36 force field (Huang and MacKerell, 2013). Non-
bonded interactions were carried out using a cut-off distance of
12 Å, with a switching distance of 10 Å. With periodic boundary
conditions, the Particle Mesh Ewald method was employed for
calculations of electrostatic energy (Darden et al., 1993). The
Cd-SrtB, crystal waters and peptides (PPKTG, SPKTG, NPKTG,
and NPQTN) were first restrained to the positions reported in
the X-ray crystallography and then gradually released, first on
the side chains and then the entire peptide and protein. No
hydrogen atom is restrained at all time. After a 1.25 ns canonical
ensemble (NVT) heating process and a short isothermal–
isobaric (NPT) equilibration, the whole system was allowed for
a productive run for 9 ns in a NPT ensemble at 310K and
1 atm, respectively controlled by solvent friction and Nosé-
Hoover Langevin piston (Feller et al., 1995). MD simulations
trajectories are further analyzed by VMD, MDAnalysis toolkit
(Michaud-Agrawal et al., 2011) and in-house programs coded in
python.
Contact Frequency Analysis for the P4
Residue of Different Substrate Peptides
To understand the role of the P4 residue in the substrate peptides,
we analyzed the contact frequency of the P4 residue of a peptide
with Cd-SrtB1N26. At every frame, a residue in Cd-SrtB1N26
situating within 4.0 Å from the P4 residue of the substrate
peptides is marked as a contact. For each contacting residue, the
contacting percentage is defined as the number of frames that the
residue is in contact divided by total number of frames in MD
simulations.
Root-Mean Square Fluctuations (RMSF)
Analysis for Peptide Residues
To calculate the root-mean square fluctuations (RMSF) for a
residue, we first iteratively superimposed the peptides in all MD
snapshots to their mean positions by Kabsch’s approach (Kabsch,
1976) until the process converges. RMSF of a residue is calculated
as
√∑N
i=1
∑M
k=1(Xi,k − Xi)2
NM , where N is the number of heavy atoms
in this residue; M is the total number of frames; Xi,k is the i-th
heavy atom in the k-th frame and X¯i is the mean position for
atom i over all the frames.
RESULTS
Catalytic Activity of the Recombinant
Purified Cd-SrtB1N26
The recombinant 6xHis-tagged C. difficile sortase enzyme with
a deletion of 26 residues at the N-terminal transmembrane
domain, designated as Cd-SrtB1N26, was overexpressed
in Escherichia coli BL21 (DE3) and purified using an Ni-
NTA affinity column (Supplementary Figure 1A). Size
exclusion chromatography revealed that Cd-SrtB1N26 was
eluted at a volume corresponding to an apparent molecular
weight of approximately 24 kDa (Supplementary Figure
1B), suggesting that Cd-SrtB1N26 exists as a monomer in
solution.
To confirm whether the recombinant purified Cd-SrtB1N26
retains protease activity, we constructed a fluorescently
labeled peptide to observe the fluorescence signal after Cd-
SrtB1N26 cleaves the substrate peptide in vitro (Figure 1A).
In this construct, the known peptide substrate PPKTG (van
Leeuwen et al., 2014) is sandwiched between a fluorophore
and quencher. When the peptide remains intact, the intrinsic
fluorescence is considerably reduced because of the proximity
between the fluorescence donor and quenching acceptor.
When the peptide is cleaved, the un-quenched fluorophore
gives an enhanced fluorescent signal. To assess whether
the previously described sortase inhibitors can inhibit the
catalytic activity of Cd-SrtB1N26, MTSET, AAEK1, and
curcumin (Maresso et al., 2007; Hu et al., 2013; Donahue
et al., 2014) (Supplementary Figure 2) were examined using
the fluorescence resonance energy transfer (FRET)-based
assay. The concentration-dependent inhibitory effects of
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MTSET (Figure 1B), AAEK1 (Figure 1C), and curcumin
(Figure 1D) on the cleavage activity of the recombinant
Cd-SrtB1N26 were observed as the fluorescence signals were
reduced when the inhibitors were added to the reactions
comprised of Cd-SrtB1N26 and fluorogenic peptides. The results
further verified the recombinant Cd-SrtB1N26 is catalytically
active.
Crystal Structure of Cd-SrtB1N26
Cd-SrtB1N26 comprises 198 residues with a 6xHis tag at the C-
terminus. Cd-SrtB1N26 crystallized in space group I23, with the
unit cell parameters a = b = c = 121.25 Å and α = β = γ =
90◦. The crystal structure of Cd-SrtB1N26 was solved at 2.8 Å
resolution by using the molecular replacement method, revealing
one molecule in the crystallographic asymmetric unit. Most of
the electron density was visible and interpretable for reliable
model building. However, the density map for residues 27 and
28, 162–167, 210–216, and 225 as well as the C-terminal 6xHis
tag was disordered. The crystallographic data and refinement
statistics are summarized in Table 1. Validation of the Cd-
SrtB1N26 structure by using theMolProbity program (Chen et al.,
2010) revealed no phi–psi angles in the disallowed region of the
Ramachandran map.
The Cd-SrtB1N26 structure possesses the sortase-unique
protein fold, comprising eight β-strands (β1–β8), three α-
helices (H1, H4, and H5), two 310-helices (H2 and H3), and
several loops (Figure 2A). Resembling other sortase structures
(Frankel et al., 2007; Kang et al., 2011; Jacobitz et al., 2014),
the central β-barrel of Cd-SrtB1N26 is formed by strands β1,
β2, β5, and β6 on one side and by strands β3, β4, β7, and β8
on the other side. The characteristic N-terminal helix bundle,
absent in SrtA structures and unique to SrtB, is composed of
a 13-residue α-helix (H1), a 310-helix (H2), and a loop. The
other 310-helix (H3) and a short α-helix (H4) are positioned
between β4 and β5; H5 is inserted between the longest β-
strand β6 and β7. The loop connecting β7 and β8 that has
been postulated for accommodating peptidoglycan substrate
binding was not visible in our structure, implying the flexibility
of the large loop. Consistent with previous studies on sortase
structures, β4, β7, and β8 of the β-barrel forming the Cys–
His–Arg triad of Cd-SrtB1N26 appears in a concave surface
(Figure 2B). The catalytic residues Cys209 and His116 are
located slightly beyond the C-terminal ends of β7 and β4,
whereas Arg217 is anchored at the beginning of β8 (Figure 2C).
A crystal structure of a catalytically inactive C. difficile mutant
SrtB1N32,C226A (PDB 4UX7) was published (Chambers et al.,
2015). Superimposition of the catalytic residues of SrtB structures
from C. difficile (PDB 5GYJ and 4UX7) (Chambers et al.,
2015), S. aureus (PDB 1NG5) (Zhang et al., 2004), B. anthracis
(PDB 1RZ2) (Zhang et al., 2004), and S. pyogenes (PDB 3PSQ)
(Kang et al., 2011) shows the conservation of the active site
(Supplementary Figure 3).
Cd-SrtB1N26 is structurally equivalent to Cd-SrtB1N32,C226A
(Chambers et al., 2015). However, visualizing the sulfhydryl
group of the catalytic cysteine residue in Cd-SrtB1N26 is
essential for facilitating our understanding of the substrate-
specific catalysis of Cd-SrtB.
In silico Model of the Cd-SrtB1N26–PPKTG
Complex
To gain structural insights into how Cd-SrtB1N26 recognizes
PPKTG, we performed computational modeling based on the
crystal structure of the Sa-SrtB–NPQT∗ complex (PDB 4LFD)
(Jacobitz et al., 2014) for predicting the Cd-SrtB1N26–PPKTG
structure. In the Sa-SrtB–NPQT∗ structure, the substrate-
binding pocket is delineated by a groove near the active site
residues within the strands β4 and β7 and within loops β2/β3,
β6/β7, and β7/β8. The NPQT∗ peptide was bound to Sa-SrtB
in an “L-shaped” structure via hydrophobic interactions with
Leu96, Tyr128, Tyr181, and Ile182 and via hydrogen bonds
with Asn92, Thr177, Glu224, and Arg233. Moreover, the almost
superimposable hydrophobic residues from S. aureus with the
corresponding residues from C. difficile underlies the importance
of their function (Supplementary Figure 4) and imply that
the Cd-SrtB substrate may be positioned in a similar pattern
within the hydrophobic groove. Therefore, we superimposed the
structure of Sa-SrtB–NPQT∗ onto Cd-SrtB1N26, mutatedNPQT∗
to PPKT and added a glycine in the C-terminus in silico using the
software VMD 1.9.2 (Humphrey et al., 1996) as an initial model
of the Cd-SrtB1N26–PPKTG complex. In addition, the missing
residues and loops in the Cd-SrtB1N26 structure, including theN-
and C-terminal residues (27, 28, and 225), and residues located
on the β6/β7 (162–167) and β7/β8 (210–216) loops were modeled
using UCSF CHIMERA (Yang et al., 2012). To refine the docking
pose of the PPKTG in the catalytic pocket of Cd-SrtB1N26,
energy minimization and MD simulations were conducted by
gradually releasing the restraints on PPKTG, first on the side
chains and then on the entire peptide, whereas the Cd-SrtB1N26
residues and crystal waters were restrained to their atomic
positions in the Cd-SrtB1N26 structure at all times during the
simulations.
The results from the computational modeling and
unrestrained MD simulations suggest that PPKTG stays in
the active site, forming a L-shape with a bend toward the
N-terminus, resembling the structure of Sa-SrtB–NPQT∗
complex (Jacobitz et al., 2014) (Figure 3A). The sulfhydryl
group of Cys209 is 5.0 Å from the carbonyl carbon of the
threonine residue at the P1 position (Schechter and Berger,
1967), which is slightly further apart as compared with that
of NPQT∗ in Sa-SrtB (Figure 3B). The side chain of Arg217
is hydrogen bonded to the hydroxyl oxygen of P1 Thr. The
P2 Lys forms a hydrogen bond with Ser163 and salt-bridge
interactions with Asp164. Moreover, the prolyl ring of P4 Pro
noncovalently interacts with the aromatic ring of Tyr167. To
assess whether Ser163 and Tyr167 are involved in substrate
interactions as predicted in the structural model, two mutants
that replace Ser163 and Tyr167 with alanine were generated
in Cd-SrtB1N26 by site-directed mutagenesis. By performing
the FRET-based assay, we observed that the cleavage activity
of mutants Cd-SrtB1N26,S163A and Cd-SrtB1N26,Y167A was
substantially reduced compared to wild-type Cd-SrtB1N26
(Figure 3C). The results indicate that the alanine substitution
of Ser163 and Tyr167 did affect the interactions between
Cd-SrtB1N26 and PPTKG, resulting in the reduced florescence
signals.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 5 November 2016 | Volume 6 | Article 160
Yin et al. Substrate Specificity of C. difficile Sortase
FIGURE 1 | Enzymatic activity and inhibition of Cd-SrtB1N26 by using a FRET-based assay. (A) Schematic representation of the peptide substrate PPKTG
sandwiched between Edans and Dabcyl as the fluorophore quencher, respectively. (B–D) Catalytic activity of Cd-SrtB1N26 and the effect of inhibitors monitored using
the FRET-based assay. PPKTG was incubated with recombinant purified SrtB1N26. The increase in the relative fluorescence signal was observed when PPKTG was
cleaved by Cd-SrtB1N26. The enzymatic cleavage of Cd-SrtB1N26 was inhibited by adding (B) 0.5, 1, and 2mM of MTSET; (C) 0.03, 0.3, 3, and 30mM of AAEK1;
and (D) 0.6 and 6mM of curcumin.
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FIGURE 2 | Crystal structure of Cd-SrtB1N26. (A) Ribbon diagram of the SrtB1N26 structure comprising three α-helices (H1, H4, and H5), two 310-helices (H2
and H3), and eight β-strands (β1–β8). Helices and β-strands are colored in purple and cyan, respectively. The flexible loops are presented in dashes. (B) Surface
representation of Cd-SrtB1N26 structure. The catalytic residues Cys209, His116, and Arg217 are colored in yellow, red, and blue, respectively. (C) Part of the overall
omit map contoured at 1.0 sigma revealing the side-chain density of the catalytic Cys–His–Arg triad.
Specificity Determinants of Substrate
Peptides
To have a better understanding of specific recognition of the
substrate peptide PPKTGbyCd-SrtB, we also constructedmodels
of Cd-SrtB1N26–SPKTG, Cd-SrtB1N26–NPKTG, and Cd-
SrtB1N26–NVQTG complexes in the same way as constructing
model of Cd-SrtB1N26–PPKTG complex. Subsequently, we
performed molecular dynamics (MD) simulations to analyze
the residues in Cd-SrtB1N26 and the contact frequency of those
residues with different substrate peptides (Supplementary Figure
5). It is observed that the P4 residues in PPKTG and SPKTG are
stabilized by residues of Cd-SrtB1N26 located in binding pocket
(Tyr101–Arg102, Ser163–Tyr167 for PPKTG, and Asp164–167,
Phe213–Asp214 for SPKTG) (Figure 4). Our results show that
the P4 residue of PPKTG in Cd-SrtB1N26–PPKTG complex
interacts with Asp166 for about 80% of the simulations time
(10 ns) and forms hydrogen bonds with Asp166; while the P4
residues in NPKTG and NVQTG do not specifically interact
with any residue in Cd-SrtB1N26 (Figure 4 and Supplementary
Figure 5). Moreover, we assumed that a peptide would be
subjected to a conformation that allows Cd-SrtB to achieve a
better catalytic efficiency if the distance (DISCys-Thr) between
the sulfhydryl group of cysteine residue in Cd-SrtB and the
carboxyl carbon of threonine residue in peptide is relatively
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 7 November 2016 | Volume 6 | Article 160
Yin et al. Substrate Specificity of C. difficile Sortase
FIGURE 3 | A computational model of the Cd-SrtB1N26–PPKTG complex. (A) Superimposed structures of the Sa-SrtB–NPQT* and Cd-SrtB1N26–PPKTG
models. Blue, Sa-SrtB. Cyan, Cd-SrtB1N26. NPQT* and PPKTG are presented in green and magenta, respectively. (B) The atomic interactions between PPKTG and
Cd-SrtB1N26 in the structural model. The hydrogen bond is colored in yellow. The distance from the sulfhydryl group of Cys209 to the carbonyl carbon of P1 Thr is
represented in red. (C) Catalytic activity of Cd-SrtB1N26 with mutation monitored using the FRET-based assay. PPKTG was incubated with recombinant purified
SrtB1N26, SrtB1N26,Y167A, and SrtB1N26,S163A. The increase in the relative fluorescence signal was observed when PPKTG was cleaved by Cd-SrtB1N26. The
enzymatic cleavage of Cd-SrtB1N26 was inhibited with Y167A and S163A mutations.
short (Donahue et al., 2014; Chambers et al., 2015). We therefore
examined distance distributions for four peptides of interest
throughout 10 ns simulations. The distances are found to
be 5.91 ± 0.53 Å, 5.81 ± 0.75 Å, 6.94 ± 0.74 Å, and 7.11
± 0.77 Å for Cd-SrtB1N26–PPKTG, Cd-SrtB1N26–SPKTG,
Cd-SrtB1N26–NPKTG, and Cd-SrtB1N26–NVQTG, respectively
(Figure 5). To further explore the role of the P4 residues of
peptides in substrate specificity, we calculated their root-mean
square fluctuations (RMSFs) of the peptides in Cd-SrtB1N26–
PPKTG, Cd-SrtB1N26–SPKTG, Cd-SrtB1N26–NPKTG, and
Cd-SrtB1N26–NVQTG. The RMSFs are 0.19, 0.38, 0.48, and 0.58
Å for PPKTG SPKTG, NPKTG and NVQTG, respectively. The
higher stability of P4 residues in (P/S)PKTG seen in our dynamic
simulations correlates to the shorter DISCys-Thr and previously
shown higher reaction activity (Donahue et al., 2014; Chambers
et al., 2015).
DISCUSSION
In this work, we have presented the crystal structure of the
catalytically active SrtB from C. difficile and provided a plausible
interaction scheme to understand how SrtB recognizes the
unique (S/P)PXTG motif.
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FIGURE 4 | Contact frequency (to the P4 residue of substrate peptides) for residues in Cd-SrtB1N26. Cd-SrtB1N26 are shown in surface representation and
opaque for the cases of Cd-SrtB1N26–PPKTG (upper-left), Cd-SrtB1N26–SPKTG (upper-right), Cd-SrtB1N26–NPKTG (lower-left) and Cd-SrtB1N26–NVQTG
(lower-right). Different peptides are shown as black line, with the P4 residue labeled by ball-and-stick in CPK. The increased contact frequency for the P4 residues in
different peptides is colored from blue to red for the purpose of easier visualization.
The P4 residue of the sortase substrate is likely to be the
specificity determinant. Based on our computational model
of Cd-SrtB1N26–PPKTG complex, we are able to identify
that the hydrophobic residue Tyr167 in Cd-SrtB1N26 forms
specific interaction with P4 Pro in PPKTG, confirmed by site-
directed mutagenesis and FRET-based assay (Figure 3). This
hydrophobic interaction between sortase and substrate has
not been seen in the current available crystal structures and
may be unique to the Cd-SrtB1N26–PPKTG complex. In the
structure of Sa-SrtB–NPQT∗ complex, P4 Asn in NPQT∗ is
hydrogen bonded to the carbonyl backbone of Thr177 within
the β6/β7 loop in Sa-SrtB (Jacobitz et al., 2014). The residue
Thr177 in Sa-SrtB is structurally equivalent to that of Ser163 in
Cd-SrtB1N26. However, structural superposition shows Ser163
in Cd-SrtB1N26 is too far away to interact with P4 Asn
in Sa-SrtB–NPQT∗. Moreover, we also identified that Ser163
interacts with P2 Lys in PPKTG. As Tyr167A and Ser163A
mutants exhibited reduced hydrolytic activity (Figure 3), we
concluded that these two residues play important roles in
specific substrate-binding and that the abolishment of the
specific interactions affects the cleavage activity by Cd-SrtB1N26.
Taken together, the structural analyses have provided partial
explanation why Cd-SrtB1N26 does not recognize the NPQTN
sorting signal. However, the actual crystal structure of Cd-SrtB–
(S/P)PKT∗ is required to disclose the atomic interactions of the
complex.
The simulation studies on the structural models of
Cd-SrtB1N26–PPKTG, Cd-SrtB1N26–SPKTG, Cd-SrtB1N26–
NPKTG, and Cd-SrtB1N26–NVQTG complexes suggest that
the stability of P4 residue may have an effect on the position
P1 residue and DISCys-Thr (Figures 4, 5). It seems reasonable
to imply that the P4 Pro in PPKTG plays a role in configuring
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FIGURE 5 | The distribution of distances between Cys209 (on SrtB1N26) and Thr4 (on the peptides) for four examined peptides. Distances between the
catalytic Cys209 in Cd-SrtB1N26 (upper-left) and Thr4, the P4 residue in the peptides of Cd-SrtB1N26–PPKTG (blue), Cd- SrtB1N26–SPKTG (green),
Cd-SrtB1N26–NPKTG (red) and Cd-SrtB1N26–NVQTG (black) of all the snapshots in simulations, are plotted in histogram. Mean distance and deviation for each
peptide are provided in the table (upper-right). X-axis is the distance from the sulfur atom of Cys209 to the carboxyl carbon of the Thr in the peptides.
the substrate peptide to a preferred conformation, permitting
Cd-SrtB to perform a more efficient cleavage. Furthermore,
PPKTG and SPKTG that have a better Cd-SrtB1N26 hydrolytic
activity than NPKTG and NVQTG peptides (Donahue et al.,
2014; Chambers et al., 2015) are found to have comparatively
high contacting frequency with Cd-SrtB1N26 via their P4 residue
and a shorter DISCys-Thr throughout the simulations. It suggests
the stabilization of P4 residue by surrounding loops near the
active site can refrain the mobility of substrate peptides and
therefore result in a shorter DISCys-Thr prompted for catalysis.
The specificity determinant that associates with P4-led peptide
conformation provides a molecular basis for specific recognition
of PPKTG by Cd-SrtB.
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